STOCK TITAN

Dorman Products Financials

DORM
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Dorman Products (DORM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 55 / 100
Financial Profile 55/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
53

Dorman Products has an operating margin of 14.1%, meaning the company retains $14 of operating profit per $100 of revenue. This results in a moderate score of 53/100, indicating healthy but not exceptional operating efficiency. This is down from 14.6% the prior year.

Growth
43

Dorman Products's revenue grew 6.0% year-over-year to $2.1B, a solid pace of expansion. This earns a growth score of 43/100.

Leverage
96

Dorman Products carries a low D/E ratio of 0.27, meaning only $0.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
59

Dorman Products's current ratio of 3.09 indicates adequate short-term liquidity, earning a score of 59/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
34

Dorman Products has a free cash flow margin of 3.5%, earning a moderate score of 34/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
42

Dorman Products's ROE of 13.8% shows moderate profitability relative to equity, earning a score of 42/100. This is down from 14.7% the prior year.

Altman Z-Score Safe
4.38

Dorman Products scores 4.38, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong
8/9

Dorman Products passes 8 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
0.56x

For every $1 of reported earnings, Dorman Products generates $0.56 in operating cash flow ($113.6M OCF vs $204.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe
10.5x

Dorman Products earns $10.5 in operating income for every $1 of interest expense ($299.5M vs $28.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.1B
YoY+6.0%
5Y CAGR+14.3%
10Y CAGR+10.2%

Dorman Products generated $2.1B in revenue in fiscal year 2025. This represents an increase of 6.0% from the prior year.

EBITDA
$333.1M
YoY+1.9%
5Y CAGR+15.8%
10Y CAGR+7.5%

Dorman Products's EBITDA was $333.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.9% from the prior year.

Net Income
$204.2M
YoY+7.5%
5Y CAGR+13.8%
10Y CAGR+8.3%

Dorman Products reported $204.2M in net income in fiscal year 2025. This represents an increase of 7.5% from the prior year.

EPS (Diluted)
$6.64
YoY+8.1%
5Y CAGR+15.0%
10Y CAGR+9.8%

Dorman Products earned $6.64 per diluted share (EPS) in fiscal year 2025. This represents an increase of 8.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$75.7M
YoY-60.5%
5Y CAGR-11.1%
10Y CAGR+0.7%

Dorman Products generated $75.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 60.5% from the prior year.

Cash & Debt
$49.4M
YoY-13.5%
5Y CAGR-20.5%
10Y CAGR-4.5%

Dorman Products held $49.4M in cash against $402.4M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
30M
YoY-0.6%
5Y CAGR-1.1%
10Y CAGR-1.4%

Dorman Products had 30M shares outstanding in fiscal year 2025. This represents a decrease of 0.6% from the prior year.

Margins & Returns

Gross Margin
42.1%
YoY+2.0pp
5Y CAGR+7.1pp
10Y CAGR+3.8pp

Dorman Products's gross margin was 42.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.0 percentage points from the prior year.

Operating Margin
14.1%
YoY-0.5pp
5Y CAGR+1.9pp
10Y CAGR-4.1pp

Dorman Products's operating margin was 14.1% in fiscal year 2025, reflecting core business profitability. This is down 0.5 percentage points from the prior year.

Net Margin
9.6%
YoY+0.1pp
5Y CAGR-0.2pp
10Y CAGR-1.9pp

Dorman Products's net profit margin was 9.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.1 percentage points from the prior year.

Return on Equity
13.8%
YoY-0.9pp
5Y CAGR+1.3pp
10Y CAGR-4.0pp

Dorman Products's ROE was 13.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$38.0M
YoY-3.7%
5Y CAGR+19.7%
10Y CAGR+5.8%

Dorman Products invested $38.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.7% from the prior year.

DORM Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $537.9M-1.1% $543.7M+0.5% $541.0M+6.6% $507.7M-4.9% $533.8M+6.0% $503.8M+0.2% $503.0M+7.3% $468.7M
Cost of Revenue $308.8M+2.2% $302.3M-6.0% $321.4M+7.2% $300.0M-3.9% $312.1M+4.0% $300.0M-1.2% $303.6M+5.7% $287.3M
Gross Profit $229.1M-5.1% $241.4M+10.0% $219.5M+5.7% $207.7M-6.3% $221.7M+8.8% $203.8M+2.2% $199.4M+9.9% $181.4M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $141.1M+4.0% $135.7M-1.0% $137.0M+7.4% $127.6M-5.4% $135.0M+8.4% $124.5M-1.9% $126.9M0.0% $127.0M
Operating Income $31.2M-70.5% $105.8M+28.2% $82.5M+3.0% $80.1M-7.7% $86.7M+9.4% $79.3M+9.4% $72.5M+33.1% $54.4M
Interest Expense $6.8M-5.3% $7.2M+0.3% $7.2M-2.4% $7.4M-19.7% $9.2M-6.2% $9.8M-4.3% $10.2M-3.8% $10.6M
Income Tax $13.0M-44.5% $23.5M+29.6% $18.1M+9.4% $16.6M-32.2% $24.4M+54.0% $15.9M+6.0% $15.0M+36.6% $11.0M
Net Income $11.6M-84.9% $76.4M+30.2% $58.7M+2.1% $57.5M+5.5% $54.5M-1.3% $55.3M+16.5% $47.4M+44.4% $32.8M
EPS (Diluted) N/A $2.48+29.8% $1.91+2.1% $1.87 N/A $1.80+17.6% $1.53+45.7% $1.05

DORM Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $2.5B-2.3% $2.6B+3.3% $2.5B+1.8% $2.4B+0.1% $2.4B+2.6% $2.4B+3.4% $2.3B+3.0% $2.2B
Current Assets $1.5B+0.3% $1.5B+6.3% $1.4B+3.7% $1.4B+0.5% $1.4B+4.1% $1.3B+6.7% $1.2B+6.0% $1.2B
Cash & Equivalents $49.4M-10.9% $55.5M-2.4% $56.8M-6.2% $60.6M+6.1% $57.1M+26.6% $45.1M-4.9% $47.5M+37.9% $34.4M
Inventory $959.0M+6.6% $899.9M+12.7% $798.2M+8.7% $734.6M+3.8% $708.0M+6.4% $665.2M+7.2% $620.4M+0.1% $620.0M
Accounts Receivable $479.3M-7.9% $520.6M-2.2% $532.1M-4.1% $555.1M-3.3% $573.8M+0.5% $571.1M+8.5% $526.2M+8.2% $486.4M
Goodwill $387.3M-12.7% $443.8M-0.1% $444.3M+0.3% $443.2M+0.1% $442.9M-0.1% $443.3M+0.1% $443.0M-0.1% $443.3M
Total Liabilities $1.0B-5.0% $1.1B-0.2% $1.1B-1.7% $1.1B-3.6% $1.1B+0.1% $1.1B+4.2% $1.1B+3.7% $1.0B
Current Liabilities $492.8M-4.6% $516.7M-0.6% $520.1M-1.2% $526.2M-6.7% $563.8M+0.4% $561.3M+9.2% $514.1M+10.4% $465.6M
Long-Term Debt $402.4M-4.4% $421.1M-2.2% $430.3M-2.1% $439.6M0.0% $439.5M-3.4% $455.0M-1.3% $461.2M-1.3% $467.3M
Total Equity $1.5B-0.4% $1.5B+5.9% $1.4B+4.7% $1.3B+3.4% $1.3B+4.8% $1.2B+2.8% $1.2B+2.3% $1.2B
Retained Earnings $1.3B-1.0% $1.4B+5.9% $1.3B+4.5% $1.2B+3.9% $1.2B+4.8% $1.1B+2.6% $1.1B+2.1% $1.1B

DORM Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $41.6M+241.2% $12.2M+42.8% $8.5M-83.3% $51.2M-28.3% $71.4M+61.3% $44.3M-30.1% $63.3M+21.9% $52.0M
Capital Expenditures $8.2M-21.5% $10.4M+22.9% $8.4M-23.1% $11.0M+34.4% $8.2M-4.4% $8.6M-28.3% $11.9M+11.0% $10.8M
Free Cash Flow $33.5M+1738.3% $1.8M+1759.2% $98K-99.8% $40.3M-36.4% $63.2M+77.0% $35.7M-30.5% $51.4M+24.7% $41.2M
Investing Cash Flow -$8.2M+21.5% -$10.4M-22.9% -$8.4M+23.1% -$11.0M-36.0% -$8.1M+5.6% -$8.6M+28.3% -$11.9M-11.0% -$10.8M
Financing Cash Flow -$39.7M-1171.4% -$3.1M+22.6% -$4.0M+89.0% -$36.8M+27.7% -$50.9M-33.7% -$38.1M+0.7% -$38.4M+11.9% -$43.6M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

DORM Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 42.6%-1.8pp 44.4%+3.8pp 40.6%-0.3pp 40.9%-0.6pp 41.5%+1.1pp 40.5%+0.8pp 39.6%+0.9pp 38.7%
Operating Margin 5.8%-13.6pp 19.4%+4.2pp 15.3%-0.5pp 15.8%-0.5pp 16.3%+0.5pp 15.7%+1.3pp 14.4%+2.8pp 11.6%
Net Margin 2.1%-11.9pp 14.1%+3.2pp 10.8%-0.5pp 11.3%+1.1pp 10.2%-0.8pp 11.0%+1.5pp 9.4%+2.4pp 7.0%
Return on Equity 0.8%-4.4pp 5.1%+1.0pp 4.2%-0.1pp 4.3%+0.1pp 4.2%-0.3pp 4.5%+0.5pp 4.0%+1.1pp 2.8%
Return on Assets 0.5%-2.5pp 3.0%+0.6pp 2.4%+0.0pp 2.4%+0.1pp 2.3%-0.1pp 2.3%+0.3pp 2.1%+0.6pp 1.5%
Current Ratio 3.09+0.2 2.94+0.2 2.74+0.1 2.62+0.2 2.43+0.1 2.34-0.1 2.40-0.1 2.50
Debt-to-Equity 0.27-0.0 0.28-0.0 0.31-0.0 0.33-0.0 0.34-0.0 0.37-0.0 0.38-0.0 0.40
FCF Margin 6.2%+5.9pp 0.3%+0.3pp 0.0%-7.9pp 7.9%-3.9pp 11.8%+4.8pp 7.1%-3.1pp 10.2%+1.4pp 8.8%

Similar Companies

Frequently Asked Questions

Dorman Products (DORM) reported $2.1B in total revenue for fiscal year 2025. This represents a 6.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Dorman Products (DORM) revenue grew by 6% year-over-year, from $2.0B to $2.1B in fiscal year 2025.

Yes, Dorman Products (DORM) reported a net income of $204.2M in fiscal year 2025, with a net profit margin of 9.6%.

Dorman Products (DORM) reported diluted earnings per share of $6.64 for fiscal year 2025. This represents a 8.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dorman Products (DORM) had EBITDA of $333.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Dorman Products (DORM) had $49.4M in cash and equivalents against $402.4M in long-term debt.

Dorman Products (DORM) had a gross margin of 42.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Dorman Products (DORM) had an operating margin of 14.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Dorman Products (DORM) had a net profit margin of 9.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Dorman Products (DORM) has a return on equity of 13.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Dorman Products (DORM) generated $75.7M in free cash flow during fiscal year 2025. This represents a -60.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Dorman Products (DORM) generated $113.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Dorman Products (DORM) had $2.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Dorman Products (DORM) invested $38.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Dorman Products (DORM) had 30M shares outstanding as of fiscal year 2025.

Dorman Products (DORM) had a current ratio of 3.09 as of fiscal year 2025, which is generally considered healthy.

Dorman Products (DORM) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Dorman Products (DORM) had a return on assets of 8.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Dorman Products (DORM) has an Altman Z-Score of 4.38, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Dorman Products (DORM) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Dorman Products (DORM) has an earnings quality ratio of 0.56x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Dorman Products (DORM) has an interest coverage ratio of 10.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Dorman Products (DORM) scores 55 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top